# FDA EIR - Unimed Pharmaceuticals, Inc. - February 14, 2023

Source: https://www.globalkeysolutions.net/records/eir/unimed-pharmaceuticals-inc/a0fc9aa5-ef54-4994-9cbd-8f0f8517ea17

> FDA EIR for Unimed Pharmaceuticals, Inc. on February 14, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Unimed Pharmaceuticals, Inc.
- Inspection Date: 2023-02-14
- Product Type: Drugs
- Office Name: Food and Drug Administration

## Related Officers

- [Approval Manager](https://www.globalkeysolutions.net/people/michael-h-tollon/5e30e7e1-5727-4169-8faf-e5d5783ac781)
- [recipient](https://www.globalkeysolutions.net/people/nak-hyun-kim/85ea34c2-8e4c-4083-98fc-8b61e9445c3b)
- [Director of Investigations Branch](https://www.globalkeysolutions.net/people/katherine-e-jacobitz/9a713b44-95c4-43a2-83bb-8d30062d8345)

Company: https://www.globalkeysolutions.net/companies/unimed-pharmaceuticals-inc/0a411cb1-2d5b-4ecd-b601-a15549196dd3

Office: https://www.globalkeysolutions.net/offices/food-and-drug-administration/437fdb2a-5048-42aa-aaea-ea28efe65516